about
An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.Deficits in executive functions among youths with autism spectrum disorders: an age-stratified analysis.Increased gene expression of FOXP1 in patients with autism spectrum disordersAssociation between symptoms and subtypes of attention-deficit hyperactivity disorder and sleep problems/disorders.Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder.Executive function in adolescence among children with attention-deficit/hyperactivity disorder in Taiwan.Improvement of executive functions in boys with attention deficit hyperactivity disorder: an open-label follow-up study with once-daily atomoxetine.Associations between chronotypes, psychopathology, and personality among incoming college students.Demographic and perinatal factors for behavioral problems among children aged 4-9 in Taiwan.Visual memory as a potential cognitive endophenotype of attention deficit hyperactivity disorder.Association between the DAT1 gene and spatial working memory in attention deficit hyperactivity disorder.A haplotype of the norepinephrine transporter gene (SLC6A2) is associated with visual memory in attention-deficit/hyperactivity disorder.Disturbed microstructural integrity of the frontostriatal fiber pathways and executive dysfunction in children with attention deficit hyperactivity disorder.Neural substrates of behavioral variability in attention deficit hyperactivity disorder: based on ex-Gaussian reaction time distribution and diffusion spectrum imaging tractography.Psychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, Version IV Scale-Teacher Form.Association between childhood sleep problems and perinatal factors, parental mental distress and behavioral problems.Executive functions as endophenotypes in ADHD: evidence from the Cambridge Neuropsychological Test Battery (CANTAB).Differential brain activations in adult attention-deficit/ hyperactivity disorder subtypes: a counting Stroop functional MRI study.Serotonin-norepinephrine reuptake inhibitor-associated mixed episode in an adolescent with schizoaffective disorder.Differential effects of methylphenidate and atomoxetine on intrinsic brain activity in children with attention deficit hyperactivity disorder.Association between morningness-eveningness and behavioral/emotional problems among adolescents.Different neural substrates for executive functions in youths with ADHD: a diffusion spectrum imaging tractography study.Visual memory and sustained attention impairment in youths with autism spectrum disorders.Associations of symptoms and subtypes of attention-deficit hyperactivity disorder with visuospatial planning ability in youth.Emotional/behavioral problems and functional impairment in clinic- and community-based children with attention-deficit/hyperactivity disorder in Taiwan.Psychometric properties of the Chinese version of Strength and Difficulties Questionnaire.Improving visual memory, attention, and school function with atomoxetine in boys with attention-deficit/hyperactivity disorder.A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder.A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine in Taiwanese children and adolescents with attention-deficit/hyperactivity disorder.Differential therapeutic effects of 12-week treatment of atomoxetine and methylphenidate on drug-naïve children with attention deficit/hyperactivity disorder: A counting Stroop functional MRI study.Impaired sustained attention, focused attention, and vigilance in youths with autistic disorder and Asperger's disorderAssociation between the dopamine transporter gene and the inattentive subtype of attention deficit hyperactivity disorder in TaiwanPsychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, version IV scale – parent formThe interactions between religion, religiosity, religious delusion/hallucination, and treatment-seeking behavior among schizophrenic patients in Taiwan
P50
Q34671921-551E3EF5-5A7B-4425-9A4D-D034EDBE1935Q36919635-7F9F61B3-4268-46FF-90AF-9E3936B77B3AQ37045770-A4F81106-D75A-49DC-B3CC-29B44A700DBCQ43090500-8B0F9FD8-CAEE-4D73-9CEF-618D15CA3637Q43180467-6A1FA7E2-6E41-47BB-BEE9-A88F9DC663AEQ43249954-4D7E17B6-083F-4519-8352-D2D3D0B2E2DCQ43256690-EEA4B3ED-9ADF-41B9-92EB-7C4AD1D047A3Q43448075-CAC3A5D1-98CB-4F75-BA0C-67ECF784ABECQ43577270-D14D7ED3-18FA-465E-887D-7CF3DE372976Q44778054-25A0D672-CA3E-4548-B2EB-345116FA32FDQ45008529-CBF8D5B6-1BC2-4201-8536-2FC176D979D9Q45059038-356821E8-D1F1-4DE9-B50F-33285318CF2EQ45826934-3CC978FF-AF1B-4594-A797-F959C59F696EQ46246475-534938F3-09EE-483C-97F4-857B256262C3Q46264535-752F7055-F608-4DCD-A9DA-AC00CB1DD279Q46953568-C81F0215-E60E-4D96-8157-102970946099Q47413751-7402E7DD-45D9-4D32-AA94-60C2532E28CBQ48199966-79DE4E3B-1266-4BE6-AF9D-4634D6CA8A20Q48285000-7809C89E-5D06-4778-809A-8E02FAFF4B5AQ48446669-937DA0D5-1BC7-41BE-9A27-0E9C0ED52B53Q48468312-5496A18F-12BE-4FA1-9201-F7CB8E4EDFFBQ49026457-98B1913A-24A8-42DB-A71E-C25CD7FEFA84Q50311934-11E9DE03-0D1B-4E80-A73A-FA60698FAD20Q50702926-DEB7EAF2-264B-4CB9-AAE9-09F09E1F3883Q50711961-C07E16A3-A3A1-4655-A357-5BA8FFC24492Q50721773-37A93F74-8FA9-49E2-B31F-80ED7613E799Q50738660-DE86B763-F8B5-4927-900A-9F39AC79DA7AQ50744430-FDA4B302-CD3F-4C13-BF66-25745CAC7B40Q51899717-ED066AD2-64A4-4354-A35D-00DEC1053F15Q52148809-52B3CAA1-A035-4F96-B492-9F9B71D364B4Q57980611-39DC39C7-A715-4EB2-9982-51EEA5050DDAQ57980703-330D453E-58ED-44B4-B2CF-F195B5BE8484Q57980769-D938CD77-19A0-4516-97B3-F98296925777Q84689976-E93B5121-73C8-4402-9267-7F75B8495BD7
P50
description
researcher ORCID ID = 0000-0001-6658-7359
@en
wetenschapper
@nl
name
Chi-Yung Shang
@ast
Chi-Yung Shang
@en
Chi-Yung Shang
@es
Chi-Yung Shang
@nl
type
label
Chi-Yung Shang
@ast
Chi-Yung Shang
@en
Chi-Yung Shang
@es
Chi-Yung Shang
@nl
prefLabel
Chi-Yung Shang
@ast
Chi-Yung Shang
@en
Chi-Yung Shang
@es
Chi-Yung Shang
@nl
P106
P1153
7005398194
P31
P496
0000-0001-6658-7359